Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Axogen Inc's Business Segments

Axogen Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY
Reportable Segments
1
Per the company's own filing, this quarter
Largest Segment
Non-US
2.9% of revenue
Total Revenue
$ 70
Consolidated, this quarter
Regions Reported
1
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/AXGN/segments
https://api.csimarket.com/api/v1/companies/AXGN/geographic
https://api.csimarket.com/api/v1/companies/AXGN/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - FY

3%largest
  • Non-US2.9%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Non-USFY$ 22.9%-

Revenue Share by Region - FY

1%largest
  • Non-US1%

Revenue by Geographic Region - FY

RegionPeriodRevenue
(Millions)
% of Total
Non-USFY$ 11%

Annual Results

Revenue Share by Reportable Segment - FY

3%largest
  • Non-US2.9%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Non-USFY$ 22.9%-

Description of Axogen Inc

Axogen, Inc. is a company that develops and markets innovative surgical solutions for peripheral nerve injuries. The company was founded in 2002 and is headquartered in Alachua, Florida. Axogen's mission is to provide surgeons with products and techniques that will allow them to precisely repair or replace damaged peripheral nerves to restore function.

Axogen has a portfolio of products that includes nerve grafts, nerve connectors, and platforms that are designed to facilitate the surgical repair of nerves. Some of Axogen's key products include:

1. Avance Nerve Graft – a processed human nerve allograft that is used to bridge gaps in damaged peripheral nerves.

2. Axoguard Nerve Connector – a collagen scaffold for connecting two severed peripheral nerves.

3. Axotouch Two-Point Discriminator – a handheld device for testing the sensitivity of nerves.

In addition to its product portfolio, Axogen is also focused on developing new technologies and techniques for nerve repair. The company has an active research and development program and partners with leading academic and clinical institutions to advance the field of peripheral nerve repair.

Axogen's products are used in a variety of surgical procedures, including reconstruction after trauma or tumor removal, as well as in the treatment of chronic conditions such as carpal tunnel syndrome and diabetic neuropathy.

Axogen has a strong track record of growth and profitability, with revenues reaching $171 million in 2020. The company has a market capitalization of over $2 billion and is listed on the NASDAQ Global Select Market.

Overall, Axogen is a leading company in the field of peripheral nerve repair and has established itself as a key player in this growing market. Its innovative products and commitment to research and development make it well-positioned for continued success in the coming years.
Axogen Inc.: Extensive Overview of Segments, Products, and Services

Company Overview:
Axogen Inc. is a pioneering medical technology company that specializes in developing and manufacturing innovative surgical solutions specifically targeted for the repair and regeneration of peripheral nerves. The core mission of Axogen is to enhance patient outcomes and improve the quality of life for individuals who suffer from serious nerve injuries caused by trauma or underlying conditions.



Segments:

Axogen operates primarily in two key segments:

1. Surgical Segment:
This segment focuses on providing groundbreaking surgical solutions tailored for the management of peripheral nerve injuries. Products within this segment are specifically designed to facilitate the repair and restoration of functional nerve pathways damaged by various causes, including surgical trauma, automotive accidents, and sports injuries.

2. Wound Care Segment:
The Wound Care segment centers on delivering specialized products and services for treating chronic and complex wounds. This segment emphasizes the promotion of healing in areas where nerve damage or surgical interventions may lead to slower or complicated recovery processes.



Products:

Axogen offers a comprehensive range of products that support nerve repair and regeneration. Noteworthy products include:

1. Avancee Nerve Graft:
- The Avancee Nerve Graft is a biologically active nerve conduit designed to repair peripheral nerves. This product serves as a bridge across nerve gaps, allowing for the alignment and reconnection of the damaged nerve ends. It incorporates growth factors and extracellular matrix elements to promote enhanced nerve regeneration over time.

2. Axoguarde Nerve Connector:
- The Axoguarde Nerve Connector acts as a biologically active interface that bridges the gap between two severed nerve ends. It is scientifically engineered to encourage nerve regeneration and restore function, utilizing a structure that supports the natural healing process while reducing scarring and inflammation.

3. Axoguarde Nerve Protector:
- This product is a biologically active nerve wrap that provides protection to the injured nerve during the recovery process. The Axoguarde Nerve Protector is designed to prevent mechanical damage to the nerve post-surgery while maintaining a supportive environment for regeneration through its specialized material and properties.

4. NerveGene:
- NerveGene is a proprietary formulation that comprises biologically active components meant to stimulate and promote the growth of nerve cells. It is employed to enhance nerve regeneration and to optimize recovery after surgical interventions, facilitating improved functional recovery for patients.



Services:

In addition to its product offerings, Axogen provides a range of services designed to support healthcare professionals in the treatment of peripheral nerve injuries. Key services include:

1. Education and Training:
- Axogen offers extensive training programs aimed at educating healthcare professionals about nerve repair and regeneration techniques. The education programs focus on the application of Axogens products, providing surgeons and medical personnel with the necessary skills and knowledge to effectively implement these solutions in clinical practice.

2. Clinical Support:
- The company maintains a dedicated clinical support team that assists healthcare providers in utilizing Axogens products. This support includes addressing inquiries, troubleshooting product-related issues, and offering clinical best practices. The goal is to ensure optimal patient outcomes and effective use of the products during surgical procedures.

3. Reimbursement Support:
- Axogen recognizes the complexities associated with healthcare billing and reimbursement. To assist its clients, the company provides comprehensive reimbursement support, helping healthcare professionals navigate the often intricate landscape of insurance claims related to nerve repair and regeneration. This service is designed to facilitate access to the necessary therapies for patients while ensuring that providers are appropriately compensated for their services.



Conclusion:

Axogen Inc. continues to be at the forefront of medical technology for nerve repair, significantly impacting the field through its dedicated segments, innovative products, and robust services. The company remains committed to improving patient lives by providing advanced solutions for peripheral nerve injuries and complex wound care challenges.